YUDEMIS ALVAREZ: Open Payments
NPI 1376188243 · MIAMI, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$321 in 13 payments from 6 companies in 2025. Trend: 2023 $198 · 2024 $311 · 2025 $321
Food & beverage: $321
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 6 | $167 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Lilly USA, LLC | 2 | $41 |
| Gilead Sciences, Inc. | 1 | $26 |
| TerSera Therapeutics LLC | 1 | $25 |
| Myriad Genetic Laboratories, Inc. | 1 | $19 |
Products named: Enhertu, VERZENIO, DATROWAY, Zoladex, KEYTRUDA, MYRISK.
Industry payments across FL — which companies pay providers there.
